There re many healthcare companies that offer wide range of products Just at your fingertips...So dxn has to resort to relisting tactic to pocket money from investors....
When IPO initial offer RM0.76 thereafter reduce to RM0.70. In this case already something wrong lor. Maybe institute buyer do not accept at 0.76 offer price.
Stock name : DXN ISIN Code : MYL5318OO000 Board : Main Market Bursa Sector : CONSUMER PRODUCTS & SERVICES Bursa Sub Sector : RETAILERS Do you wish to list any child stock / new type of securities in conjunction with the IPO/Admission to LEAP Market? : No No. of child stock / new type of securities to be listed : 0 Remarks : Unless otherwise stated, all defined terms used in this announcement shall have the same meaning as those defined in the Prospectus dated 28 April 2023 issued by DXN Holdings Bhd. ("DXN"). The enlarged issued share capital of DXN of RM218,033,360 is before the deduction of expenses directly attributable to its Public Issue of 160,000,000 Issue Shares.This announcement is not for publication or distribution, directly or indirectly, outside Malaysia or in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia), shall not constitute an offer to sell or a solicitation of an offer to purchase the IPO Shares, and is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the U.S. Securities Act), except pursuant to a registration or an applicable exemption from registration under the U.S. Securities Act. No public offering of securities is being made in the United States. You are advised to read the entire contents of the announcement or attachment. To read the entire contents of the announcement or attachment, please access the Bursa website at http://www.bursamalaysia.com
DXN CEO dr. Lim invested 20 million Euros and created China headquarters for DXN in Ningxia, China. Originally DXN Holdings Bhd is a Malaysian based M…
terlalu luar biasa Ketika ini, DXN sudah bertapak di 48 buah negara dengan mempunyai sebanyak 79 cawangan jualan serta seramai 14.9 juta ahli berdaftar.
CYBERJAYA: Syarikat jualan langsung berorientasikan kesihatan dan kesejahteraan, DXN Holdings Bhd (DXN) merancang untuk memperluaskan jenamanya meliputi dua pasaran baharu di peringkat global iaitu Afrika dan Amerika Selatan.
Pengerusi Eksekutif dan pengasas DXN, Datuk Lim Siow Jin berkata, perancangan yang akan dilaksanakan pada tahun ini melibatkan Brazil, Argentina, Algeria, Nigeria dan Mesir.
majoriti keuntungan DXN disumbangkan oleh pasaran eksport di negara-negara tertentu di Amerika Latin, Timur Tengah, Asia Selatan dan Asia Tenggara.
Katanya, wilayah tersebut menjadi pasaran utama DXN hasil daripada rangkaian produknya yang luas dan diterima baik oleh penduduk tempatan melalui penglibatan berterusan dan hubungan baik.
Mengulas lanjut, Siow Jin berkata, DXN kini mempunyai lebih 2,500 pekerja tempatan dan sejumlah 15 juta pengedar di seluruh dunia dengan 3.6 juta orang daripadanya adalah pengedar yang aktif.
DXN juga banyak membuat pelaburan ke atas kemudahan penyelidikan dan pembangunan, pembuatan serta pengeluaran syarikat tersebut.
“Pada masa ini DXN mempunyai dua kemudahan penyelidikan, 10 kemudahan pembuatan dan enam kemudahan penanaman antaranya terletak di Kedah, China, Indonesia, India dan Mexico.
“Kami berharap untuk mengekalkan prestasi pertumbuhan dengan menembusi pasaran yang lebih luas di Malaysia serta pentas antarabangsa,” ujarnya.
DXN memiliki lebih daripada 200 jenis produk yang mana kopi mewakili segmen terbesar dengan tawaran 13 jenis minuman kopi, produk makanan tambahan yang dihasilkan daripada tiga jenis bahan semula jadi termasuk ganoderma, spirulina dan juga mengkudu.
Selain itu, syarikat tersebut juga menawarkan segmen produk kecantikan dan penjagaan serta produk kesihatan lain.
DXN has consistently demonstrated robust financial results, showcasing its ability to generate substantial revenue and deliver consistent profitability. These factors indicate a solid foundation for potential future growth 💪💪💪🔥🔥🔥
OKU - 1st error - not 55 sen today, was 64 sen. On-line and Direct Selling - are the new trend in business. Health Product is a growing -not a sunset business :-)
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
speakup
26,823 posts
Posted by speakup > 2023-05-22 10:58 | Report Abuse
Buy buy buy .....until u become new major shareholders of dxn 😁 LOL